To test this, we examined peripheral blood CD4+ T cells from volunteers participating in CHMI studies with P. falciparum prior to infection and at day 15 p.i. (7 days after start of drug treatment), as we previously showed this was when Tr1 cell responses peaked (3). The gene discussed is CD4; the disease is infection.